Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Follica, a privately held developer of a novel therapy for androgenetic alopecia, has secured $5.5 million in series A financing.
Subscribe to our email newsletter
Interwest Partners led the financing and existing investors PureTech Ventures participated. The funding is expected to take the company through a clinical proof of concept study.
Rox Anderson, professor of dermatology at Harvard Medical School, and co- founder and Scientific Advisory Board Chair of Follica, said: “Our technologies for creating and manipulating hair follicles position us to treat, and perhaps eventually cure, androgenetic alopecia, other hair loss conditions, and related follicular disorders such as acne.”